Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2026 · third_quarter · Consumer Issues/Safety/Products
Issues related to federal privacy and data security, particularly as it relates to genetic data; Genomic Data Protection Act (S. 863); KIDS Act (H.R. 7757)
Client expense: Not reported · Firm income: $30,000
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Consumer Issues/Safety/Products
Issues related to federal privacy and data security, particularly as it relates to genetic data; Genomic Data Protection Act (S. 863)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Consumer Issues/Safety/Products
Issues related to federal privacy and data security, particularly as it relates to genetic data; Genomic Data Protection Act (S. 863)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Consumer Issues/Safety/Products
Issues related to federal privacy and data security, particularly as it relates to genetic data; Genomic Data Protection Act (S. 863)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Consumer Issues/Safety/Products
Issues related to federal privacy and data security, particularly as it relates to genetic data; Genomic Data Protection Act (S. 863)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Copyright/Patent/Trademark
Issues related to biopharmaceutical innovation and intellectual property (no bill); issues related to intellectual property and Bayh-Dole in the Genomic Data Protection Act (S. 863 / no House bill); induced infringement.
Client expense: Not reported · Firm income: $130,000
2025 · second_quarter · Consumer Issues/Safety/Products
Issues related to federal privacy and data security, particularly as it relates to genetic data; Genomic Data Protection Act (S. 863)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Consumer Issues/Safety/Products
Issues related to federal privacy and data security, particularly as it relates to genetic data; Genomic Data Protection Act (S. 863)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE